for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity. The Company is headquartered in New York City and operates a regional office in Barcelona, Spain. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements. CBN Is Another Cannabis Compound With Beneficial Properties. CBD, an abbreviation of cannabidiol, a non-intoxicating compound found in cannabis and hemp plants, is going viral across the globe.
Hailed for its natural anecdotal anti-inflammatory and pain-relieving properties, CBD is being added to everything from skincare to food. However, CBD is just one of the hundreds of compounds inherent to the cannabis plant. Even though THC and CBD are garnering all the buzz, there are myriad other cannabis compounds which can help alleviate a plethora of symptoms –including CBN. Innumerable outlets report that CBD is non-psychoactive. CBD is psychoactive to a much lesser degree than THC; however, it is non-intoxicating, for the most part. People in 12-step or other substance abuse recovery programs report feeling "something" on high doses of CBD, because not all CBD products are equal. Therefore consumers who do not wish to get high must be careful to choose a reputable brand with a proven below 0.3% THC content. Resin that is extracted from "marijuana" might have higher levels of THC than that derived from "hemp," but only because the legal distinction between the two refers to the THC level. Science Reveals The Cannabis Industry’s Greatest Lie: You’re Buying Weed Wrong (And So Is Everyone Else) Trump Rally Sees Joe Biden’s Presidental Odds Surge: Presidential Election Betting Update. MedMen’s Failure Is Everything Wrong With Legal Cannabis (And Is Only The First Company To Implode) "We found that CBN slightly prolongs the sleep time in barbiturate-induced sleep in mice. There is no current information that I am aware of that proves CBN is a sedative, even though it is already being marketed as such," says Zoe Sigman one of the principal researchers at Project CBD, a leading think tank and non-profit CBD information site. CBN –an abbreviation of Cannabinol– comes from the oxidation and decomposition of THC from a hemp plant, meaning that when THC is heated and exposed to Co2 (oxygen), it converts to CBN. The compound has a mild psychoactive response, slightly more so than CBD but much less than THC. "The pharmacokinetics of CBN seems to be in between 1/6 and 1/10 of the potency of the CB1 receptor (cannabinoid receptor type-1) that THC is," Sigman elaborates. CBN and CBD, either individually or combined, potentially help alleviate insomnia by causing an overall sense of mind and body tranquility and relaxation. According to Mary magazine's blog, while CBN purportedly has a sedating effect on most users, CBD purportedly tends to cause a feeling of alertness rather than sluggishness, the morning after bedtime consumption. CBN and CBD are acutely different when it comes to their effect on most consumers' appetites. While CBD can act as a mild appetite suppressant, CBN tends to stimulate one's appetite. Both CBN and CBD are known anecdotally to relieve symptoms of pain and inflammation, by potentially altering pain signals that the brain receives. One way to take advantage of these compounds' pain-relieving properties is to apply a product topically to the affected area directly. By topically applying rather than consuming these compounds, and bypassing the digestive system and liver, consumers lower the potential risk of interactions with prescription drugs. CBD may have contra-indications with a vast array of pharmaceuticals, including Warfarin or other blood thinners. Whatever the intended usage of either compound, a patient should always consult a qualified doctor, before consuming any natural remedy or supplement that potentially has unforeseen contraindications. With the recent explosion in CBD products, less scrupulous vendors that are looking to cash in on the latest fad, may not produce a high-quality product that is lab tested for purity.
Even worse, the CBD may contain useless amounts or dangerous additives. One such vendor was called out by Consumer Reports when "Researchers at Virginia Commonwealth University found that the products, all from Diamond CBD, a publicly-traded company, contained a compound called 5F-ADB. That compound, often found in illegal synthetic marijuana products such as "K2" and "Spice," can trigger paranoia and panic attacks, increase heart rate and blood pressure, and cause convulsions, organ damage, and even death, according to the Drug Enforcement Agency. ” Additionally, exercise caution when consuming product hybrids, such as CBD + Melatonin. As CBD is unregulated by the FDA and has not undergone any US clinical trials, it is unwise to take a mixture of supplements, before bedtime. Please upgrade your browser to improve your experience. Eagle Ridge Mall 762 Eagle Ridge Drive Lake Wales, FL 33859 863-676-0911.
In the Eagle Ridge Mall, at the back of the mall towards the cinema. Optical Outlets accepts a wide variety of vision insurance plans from many companies, helping you to save money on your eyewear needs. We accept vision insurance for all of our product offerings including contact lenses, frames, eyeglasses and more.